2361. Riociguat for Sarcoidosis-Associated Pulmonary Hypertension: Results of a 1-Year Double-Blind, Placebo-Controlled Trial.
作者: Robert P Baughman.;Oksana A Shlobin.;Rohit Gupta.;Peter J Engel.;Jeffrey I Stewart.;Elyse E Lower.;Franck F Rahaghi.;Joyce Zeigler.;Steven D Nathan.
来源: Chest. 2022年161卷2期448-457页
Riociguat is effective in delaying the time to clinical worsening (TCW) in patients with groups 1 and 4 pulmonary hypertension.
2362. Iron Deficiency Is Associated With More Severe Pulmonary Vascular Disease in Pulmonary Hypertension Caused by Chronic Lung Disease.
作者: Jasmine Tatah.;Jennifer L Keen.;Sasha Z Prisco.;Marc Pritzker.;Thenappan Thenappan.;Kurt W Prins.
来源: Chest. 2022年161卷1期232-236页 2363. Presentation, Diagnosis, and Management of Subglottic and Tracheal Stenosis During Systemic Inflammatory Diseases.
作者: Jennifer Catano.;Yurdagul Uzunhan.;Romain Paule.;Jérémie Dion.;Alexis Régent.;Paul Legendre.;François Gonin.;Emmanuel Martinod.;Pascal Cohen.;Xavier Puéchal.;Véronique Le Guern.;Luc Mouthon.;André Coste.;Christine Lorut.;Candice La Croix.;Sophie Périé.;Benjamin Terrier.
来源: Chest. 2022年161卷1期257-265页
Subglottic stenosis (SGS) and tracheal stenosis (TS) are characterized by a narrowing of the airways. The goal of this study was to describe the characteristics and prognosis of nontraumatic and nontumoral SGS or TS.
2364. Treatment of Mycobacterium abscessus Pulmonary Disease.
Mycobacterium abscessus is the second most common nontuberculous mycobacterial lung disease pathogen and comprises three subspecies: abscessus, massiliense, and bolletii. Subspecies identification is critical for disease management, as subspecies abscessus and bolletii have an inducible macrolide resistance gene [erm(41)] that results in clinical macrolide resistance. In contrast, subspecies massiliense does not have an active erm(41) gene and is therefore susceptible in vitro and clinically to macrolide-containing regimens. M abscessus is also vulnerable to acquired mutational macrolide resistance. Macrolide resistance has such a profoundly negative impact on M abscessus treatment response that preserving macrolide susceptibility with adequate companion drugs for macrolides is among the highest treatment priorities. After the macrolides, amikacin is regarded as the next most important drug for M abscessus treatment, although data validating that assertion are lacking. The considerations for preventing acquired macrolide resistance also apply to amikacin. Recent guidelines suggest that treatment should be guided by in vitro susceptibilities but, aside from macrolides and amikacin, no other antibiotics have a validated minimum inhibitory concentration for M abscessus. Currently, phase therapy (intensive and continuation) is recommended for M abscessus. This approach is successful with macrolide-susceptible M abscessus but not with macrolide-resistant M abscessus, in which even more aggressive therapy is not predictably successful. Newer drugs have become available, with encouraging in vitro activity against M abscessus, but in vivo validation of their superiority to current agents is not yet available. In the absence of unequivocally effective regimens, we offer suggestions for managing this treatment-refractory organism.
2365. Tyrosine Kinase Inhibitors for Acute Respiratory Failure Because of Non-small-Cell Lung Cancer Involvement in the ICU.
作者: Yacine Tandjaoui-Lambiotte.;Yanis Akrour.;Aude Gibelin.;Frederic Gonzalez.;Annabelle Stoclin.;Anne-Sophie Moreau.;Paul Jaubert.;Anne Oppenheimer.;Boris Duchemann.;Stéphane Gaudry.
来源: Chest. 2022年161卷1期284-287页 2366. Differential Effects of Electronic Hookah Vaping and Traditional Combustible Hookah Smoking on Oxidation, Inflammation, and Arterial Stiffness.
作者: Mary Rezk-Hanna.;Rajat Gupta.;Charlie O Nettle.;Daniel Dobrin.;Chiao-Wei Cheng.;Angelica Means.;Mary-Lynn Brecht.;Donald P Tashkin.;Jesus A Araujo.
来源: Chest. 2022年161卷1期208-218页
Traditional hookah smoking has grown quickly to become a global tobacco epidemic. More recently, electronic hookahs (e-hookahs)-vaped through traditional water pipes-were introduced as healthier alternatives to combustible hookah. With combustible tobacco smoking, oxidative stress, inflammation, and vascular stiffness are key components in the development and progression of atherosclerosis. The comparable effects of hookah are unknown.
2369. Addressing Sex Disparities in Lung Cancer Screening Eligibility: USPSTF vs PLCOm2012 Criteria.
作者: Mary M Pasquinelli.;Martin C Tammemägi.;Kevin L Kovitz.;Marianne L Durham.;Zanë Deliu.;Arielle Guzman.;Kayleigh Rygalski.;Li Liu.;Matthew Koshy.;Patricia Finn.;Lawrence E Feldman.
来源: Chest. 2022年161卷1期248-256页
Lung cancer is the leading cause of cancer death in women in the United States. Prospective randomized lung screening trials suggest a greater lung cancer mortality benefit from screening women compared with men.
2370. Presenting Features and Clinical Course of Chronic Nitrofurantoin-Induced Lung Toxicity.
作者: Vasilios Tzilas.;Antonios Charokopos.;Lykourgos Kolilekas.;Effrosyni Manali.;Spyridon Papiris.;Jay H Ryu.;Demosthenes Bouros.
来源: Chest. 2022年161卷3期748-752页 2371. An Integrative Genomic Strategy Identifies sRAGE as a Causal and Protective Biomarker of Lung Function.
作者: Joshua Keefe.;Chen Yao.;Shih-Jen Hwang.;Paul Courchesne.;Gha Young Lee.;Josée Dupuis.;Joseph P Mizgerd.;George O'Connor.;George R Washko.;Michael H Cho.;Edwin K Silverman.;Daniel Levy.
来源: Chest. 2022年161卷1期76-84页
There are few clinically useful circulating biomarkers of lung function and lung disease. We hypothesized that genome-wide association studies (GWAS) of circulating proteins in conjunction with GWAS of pulmonary traits represents a clinically relevant approach to identifying causal proteins and therapeutically useful insights into mechanisms related to lung function and disease.
2372. Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative.
作者: Gary M Hunninghake.;Jonathan G Goldin.;Michael A Kadoch.;Jonathan A Kropski.;Ivan O Rosas.;Athol U Wells.;Ruchi Yadav.;Howard M Lazarus.;Fereidoun G Abtin.;Tamera J Corte.;Joao A de Andrade.;Kerri A Johannson.;Martin R Kolb.;David A Lynch.;Justin M Oldham.;Paolo Spagnolo.;Mary E Strek.;Sara Tomassetti.;George R Washko.;Eric S White.; .
来源: Chest. 2022年161卷2期470-482页
Interstitial lung abnormalities (ILA) may represent undiagnosed early-stage or subclinical interstitial lung disease (ILD). ILA are often observed incidentally in patients who subsequently develop clinically overt ILD. There is limited information on consensus definitions for, and the appropriate evaluation of, ILA. Early recognition of patients with ILD remains challenging, yet critically important. Expert consensus could inform early recognition and referral.
2373. Prolonged Prehospital Time Is a Risk Factor for Pneumonia in Trauma (the PRE-TRIP Study): A Retrospective Analysis of the United States National Trauma Data Bank.
作者: Lee E Morrow.;Nikhil Jagan.;Ryan W Walters.;Robert W Plambeck.;Merrie Oshiro.;Mark A Malesker.
来源: Chest. 2022年161卷1期85-96页
Although multiple risk factors for development of pneumonia in patients with trauma sustained in a motor vehicle accident have been studied, the effect of prehospital time on pneumonia incidence post-trauma is unknown.
2374. Antibiotic Timing and Progression to Septic Shock Among Patients in the ED With Suspected Infection.
作者: Roshan Bisarya.;Xing Song.;John Salle.;Mei Liu.;Anurag Patel.;Steven Q Simpson.
来源: Chest. 2022年161卷1期112-120页
Recent medical society opinions have questioned the use of early antimicrobials in patients with sepsis, but without septic shock.
2375. SICQ Coping and the Health-Related Quality of Life and Recovery of Critically Ill ICU Patients: A Prospective Cohort Study.
作者: Edwin J Boezeman.;José G M Hofhuis.;Christopher E Cox.;Reinout E de Vries.;Peter E Spronk.
来源: Chest. 2022年161卷1期130-139页
The coping styles of the Sickness Insight in Coping Questionnaire (SICQ; positivism, redefinition, toughness, fighting spirit, nonacceptance) may affect the health and recovery of hospitalized critically ill patients.
2376. The Usefulness of the Rapid Shallow Breathing Index in Predicting Successful Extubation: A Systematic Review and Meta-analysis.
作者: Vatsal Trivedi.;Dipayan Chaudhuri.;Rehman Jinah.;Joshua Piticaru.;Arnav Agarwal.;Kuan Liu.;Eric McArthur.;Michael C Sklar.;Jan O Friedrich.;Bram Rochwerg.;Karen E A Burns.
来源: Chest. 2022年161卷1期97-111页
Clinicians use several measures to ascertain whether individual patients will tolerate liberation from mechanical ventilation, including the rapid shallow breathing index (RSBI).
2377. Early Tracheostomy for Managing ICU Capacity During the COVID-19 Outbreak: A Propensity-Matched Cohort Study.
作者: Gonzalo Hernandez.;Francisco Javier Ramos.;José Manuel Añon.;Ramón Ortiz.;Laura Colinas.;Joan Ramón Masclans.;Candelaria De Haro.;Alfonso Ortega.;Oscar Peñuelas.;María Del Mar Cruz-Delgado.;Alfonso Canabal.;Oriol Plans.;Concepción Vaquero.;Gemma Rialp.;Federico Gordo.;Amanda Lesmes.;María Martinez.;Juan Carlos Figueira.;Alejandro Gomez-Carranza.;Rocio Corrales.;Andrea Castellvi.;Beatriz Castiñeiras.;Fernando Frutos-Vivar.;Jorge Prada.;Raul De Pablo.;Antonio Naharro.;Juan Carlos Montejo.;Claudia Diaz.;Alfonso Santos-Peral.;Rebeca Padilla.;Judith Marin-Corral.;Carmen Rodriguez-Solis.;Juan Antonio Sanchez-Giralt.;Jorge Jimenez.;Rafael Cuena.;Santiago Perez-Hoyos.;Oriol Roca.
来源: Chest. 2022年161卷1期121-129页
During the first wave of the COVID-19 pandemic, shortages of ventilators and ICU beds overwhelmed health care systems. Whether early tracheostomy reduces the duration of mechanical ventilation and ICU stay is controversial.
|